Business

Recon: Sino, Boehringer ink cancer drug deal worth $7B; CVS to split pharmacy business from insurance

Welcome to Regulatory Reconnaissance, your regulatory news and intelligence briefing.

U2Fx.comU2Fx.com
Nov 6, 2026 - 00:00
 0  0
Recon: Sino, Boehringer ink cancer drug deal worth $7B; CVS to split pharmacy business from insurance
Welcome to Regulatory Reconnaissance, your regulatory news and intelligence briefing.
Read More

Tags:

Previous Article

Phoenix Tailings prepares to open rare earth separation facility at Eastman Busi...

Next Article

UA System president leaving for Purdue University - Talk Business & Politics

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

U2Fx.com
U2Fx.com

Related Posts

New York and London Retain Top Spots for Business Travel in Hickory Report - Business Travel Executive

New York and London Retain Top Spots for Business Trave...

U2Fx.com Oct 28, 2026  0  4

Exec burnout and overwork: How 10 business leaders stave off burnout

Exec burnout and overwork: How 10 business leaders stav...

U2Fx.com Jul 28, 2026  0  21

From Greenpoint merchants to Chinatown lights: Where NYC’s $8.4M small-business grants are going

From Greenpoint merchants to Chinatown lights: Where NY...

U2Fx.com Aug 18, 2026  0  22